JOURNAL ARTICLE

Benetton Scion Considers Sale of Italian Eye Care Firm Sifi.

  • Published In: Bloomberg.com, 2024. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Barbaglia, Pamela 3 of 3

Abstract

Italian eye-care firm Sifi, founded in 1935, is being considered for sale by private equity firm 21 Invest, led by Alessandro Benetton. The firm is working with Mediobanca SpA and Evercore Inc. to gauge interest in the company, with a potential sale process targeting larger health-care companies and private equity firms. The deal could value Sifi at up to €500 million ($542 million). Sifi provides therapies and medical devices for eye diseases and has expanded its presence overseas since being acquired by 21 Invest in 2015. The company is also planning to start clinical trials for its new orphan drug, Akantior, which treats fungal keratitis. [Extracted from the article]

Additional Information

  • Source:Bloomberg.com. 2024/07, pN.PAG
  • Document Type:Article
  • Subject Area:Business and Management
  • Publication Date:2024
  • Accession Number:178659823
  • Copyright Statement:Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.